NAD+
Coenzyme in cellular redox reactions; not a peptide. Blood measurements and effects are distinct endpoints.
Search names: NAD, Nicotinamide adenine dinucleotide
Evidence
Catalogue entry · see sources
Describes the linked sources, not an overall score for product quality or effectiveness.Half-life
Vital: ~5 min
Transcribed from the recorded catalogue; experimental conditions are not always specified in the value field.Statistics reference: About 45 minutes
Estimate / borrowed valueContext and sources for the statistics reference
Speculative catalogue value; no reported human half-life. NAD+ is not a peptide.
About 45 minutes · Catalogue information from PeptideTracker.ai; read the limitation above. PeptideTracker.ai · NAD+ ↗
Half-life, duration of effect and shelf life are different measures. Catalogue values may differ between variants and administration routes. Curves continue to use their stated statistics reference.
Adverse effects and limitations
Adverse effects are not fully mapped in this entry. Consult the sources for the specific compound and use.
Sources and further reading
Vital · user-supplied screen recordings, 1 Nov 2026
Find researchPubMed · NAD+↗Research information, not a personal dosing plan. Last reviewed: 2026-11-01.